CD274 and neoplasm: The patients with PD-L1 tumor proportion score (TPS) of 1% or higher were enrolled in this study, and the allogeneic NK Cells were collected from the healthy donors who were selected based on genotyping mismatch between the KIR of allogenic donors and the HLA class I of patients.